The significance of autoantibodies and immunoglobulins in acute liver failure: A cohort study

Journal of Hepatology

Volumn 47, Issue 5, 2007, Pages 664-670

  Bernal, William ^a   Ma, Yun ^a   Smith, Heather M ^a   Portmann, Bernard ^a   Wendon, Julia ^a   Vergani, Diego ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

ALF; Anti SLA; Autoimmunity; NOSA

Indexed keywords

ATORVASTATIN; AUTOANTIBODY; FENFLURAMINE; FLUTAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; LIVER ANTIGEN; NITROFURANTOIN; PARACETAMOL; PHENINDIONE; RADIOLIGAND;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HEPATITIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER INJURY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SERODIAGNOSIS;

ACETAMINOPHEN; ADULT; ANALGESICS, NON-NARCOTIC; ANTIBODIES, VIRAL; AUTOANTIBODIES; AUTOANTIGENS; COHORT STUDIES; FEMALE; HEPATITIS; HUMANS; IMMUNOGLOBULINS; LIVER FAILURE, ACUTE; MALE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RADIOLIGAND ASSAY; SENSITIVITY AND SPECIFICITY;

EID: 34848918187     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.05.011     Document Type: Article

References (38)

1. Sheron N., Keane H., Goka J., Alexander G., William S., and Wendon J. Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamics. Clin Int Care 12 (2001) 127-134
2. Sekiyama K.D., Yoshiba M., and Thomson A.W. Circulating proinflammatory cytokines IL-1 beta, TNF-alpha, and IL-6 and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 98 (1994) 71-77
3. Streetz K., Leifield L., Grundmann D., Ramakers J., Eckert K., Spengler U., et al. Tumour necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119 (2000) 446-460
4. Vaquero J., Polson J., Chung C., Helenowski I., Schiodt F.V., and Reisch J. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125 (2003) 755-764
5. Rolando N., Wade J., Davalos M., Wendon J., Philpott-Howard J., and Williams R. The systemic inflammatory response in acute liver failure. Hepatology 32 (2000) 734-739
6. Jalan R., Damink S.O., Hayes P., Deutz N.E., and Lee A. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 41 (2004) 613-620
7. Gimson A., O'Grady J., Ede R., Portmann B., and Williams R. Late-onset hepatic failure: clinical, serological and histological features. Hepatology 6 (1986) 288-294
8. Ellis A., Saleh M., Smith H., Portmann B., Gimson A., and Williams R. Late-onset hepatic failure: clinical features, serology and outcome following transplantation. J Hepatol 23 (1995) 363-372
9. Rochling F., Jones W., Chau K., DuCharme L., Mimms L.T., Moore B., et al. Acute sporadic non-A, non-B, non-C, non-D, non-E hepatitis. Hepatology 25 (1997) 478-483
10. Kyrlagkitsis I., Cramp M., Smith H., Portmann B., and O'Grady J. Acute hepatitis A virus infection: a review of prognostic factors from 25 years experience in a tertiary referral center. Hepatogastroenterology 49 (2002) 524-528
11. Wigg A., Gunson B., and Mutimer D. Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients. Liver Transpl 11 (2005) 27-34
12. Group IAH. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.
13. Czaja A., and Norman G. Autoantibodies in the diagnosis and management of liver disease. J Clin Gastroenterol 37 (2003) 315-329
14. O'Grady J. Acute liver failure. In: O'Grady J., Lake J., and Howdle P. (Eds). Comprehensive clinical hepatology. 1st ed. (2000), Mosby, London 30.20-30.31
15. Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liv Dis 23 (2003) 227-237
16. Ben-Ari Z., Samuel D., Zemel R., Baruch Y., Gigou M., Sikulere E., et al. Fulminant non-A-G viral hepatitis leading to liver transplantation. Arch Intern Med 160 (2001) 388-392
17. Halasz R., Barkholt I., Hultgren C., Ando Y., Broome U., Fischler B., et al. Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products. Gut 44 (1999) 274-278
18. Gimenez-Barcons M., Forns X., Ampurdanes S., Guilera M., Soler M., Soguero C., et al. Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver disease. J Hepatol 30 (1999) 1028-1034
19. Umemura T., Tanaka E., Ostapowicz G., Brown K.E., Heringlake S., Tassopoulos N.C., et al. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis 188 (2003) 1545-1552
20. Gow P., and Mutimer D. Non-A, Non-B fulminant hepatic failure. Arch Intern Med 161 (2001) 1013-1014
21. Gow P., Hathaway M., Gunson B., Heward J., and Mutimer D. Association of fulminant non-A non-B hepatitis with homozygosity for HLA A1-B8-DR3. J Gastroenterol Hepatol 20 (2005) 555-561
22. Hansen K., Arnason J., and Bridges A. Autoantibodies and common viral illnesses. Semin Arthritis Rheum 27 (1998) 263-271
23. Niwa Y., Sakane T., Kanoh T., Schichijo S., Wiederhold M.D., and Yokoyama M.M. Transient autoantibodies with elevated complement levels in common viral diseases. Clin Lab Immunol 13 (1984) 183-188
24. Czaja A., Shums Z., and Norman G. Nonstandard antibodies as prognostic markers in autoimmune hepatitis. Autoimmunity 37 (2004) 195-201
25. Baeres M., Herkel J., Czaja A., Wies I., Kanzler S., Cancado E.L., et al. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence and clinical characteristics. Gut 51 (2002) 259-264
26. Wies I., Brunner S., Henninger J., Herkel J., Kanzler S., Meyer zum Buschenfelde K.H., et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355 (2000) 1510-1515
27. Ma Y., Okamoto M., Thomas M., Bogdanos D.P., Lopes A.R., Portmann B., et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 35 (2002) 658-664
28. Sizer E., Bernal W., and Wendon J. Acute liver failure in the intensive care unit. In: Vincent J. (Ed). 2003 yearbook of intensive care and emergency medicine (2003), Springer, Berlin
29. O'Grady J.G., Schalm S.W., and Williams R. Acute liver failure: redefining the syndromes. Lancet 342 (1993) 273-275
30. Manns M., Kyriatsoulis A., Gerken G., Staritz M., and Meyer zum Buschenfelde K.H. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 329 (1987) 292-294
31. Ballot E., Homberg J., and Johanet C. Antibodies to soluble liver antigen: an additional marker in type 1 autoimmune hepatitis. J Hepatol 33 (2000) 208-215
32. Czaja A., Shums Z., and Norman G. Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis. Autoimmunity 35 (2002) 475-483
33. Vitozzi S., Lapierre P., Djilali-Saiah I., Marceau G., Beland K., and Alvarez F. Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection. Autoimmunity 37 (2004) 217-222
34. Gregorio G.V., Portmann B., Reid F., Donaldson P.T., Doherty D.G., McCartney M., et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 25 (1997) 541-547
35. Dietz W., Porcell O., Moon T., Peters C.J., and Purcell R.H. IgM levels and IgM-mediated immune responses in patients with acute hepatitis A, acute hepatitis B and chronic HB antigenaemia. Clin Exp Immunol 23 (1976) 69-72
36. Hanau C., Munoz S., and Rubin R. Histopathological heterogeneity in fulminant hepatic failure. Hepatology 21 (1995) 345-351
37. Lucena M., Camargo R., Andrade R., Perez-Sanchez C.J., and Sanchez De La Cuesta F. Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 33 (2001) 1130-1213
38. Kessler W., Cummings O., Eckert G., Chalasani N., Lumeng L., and Kwo P.Y. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2 (2004) 625-631